Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation
Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation have?
Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation has 91 citations in the OpenAlex counts ScholarIQ stores.
When was Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation published?
Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation has 2023 year in the ScholarIQ index.
What is the open-access status of Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation?
Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation has gold oa status in the ScholarIQ index.
What is the DOI of Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation?
The DOI for Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation is on the source record.
What is the PMID of Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation?
The PMID for Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation is on the source record.
What is the OpenAlex record for Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation?
The OpenAlex for Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation is on the source record.